Interview with Carlos Apellaniz, Healthcare Partner, Korn/Ferry Mexico
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
Address: Montes Urales 505, 3rd Floor Lomas de Chapultepec Del. Miguel Hidalgo 11000 Mexico DF ,Mexico
Tel: 55 5095 9500
Web: http://https//www.kornferry.com/
Since our inception, clients have trusted Korn/Ferry to help them recruit world-class leadership talent. Building on this heritage, today we are a single source for a wide range of leadership and talent consulting services. From our nearly 80 offices in 40 countries, we assist organizations in attracting, engaging, developing, and retaining their people. Services range from executive recruitment to leadership development programs, enterprise learning, succession planning and recruitment outsourcing.
As one of the world’s top ranked leadership and talent consulting firms, we build more effective people, teams, and organizations to drive accelerated business results, and achieve sustainable change. We work with Boards, CEOs, CHROs, and CLOs to align their talent strategy with their business strategy — bringing together deep consulting expertise with the most advanced research-validated methodologies available. Our goal is to transform the lives of the people and organizations we serve, and the worldwide leadership and talent industry.
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
The Mexican Association of Pharmaceutical Research Industries (AMIIF) represents the innovative pharmaceutical industry in Mexico, advocating for innovation and promoting dialogue with local authorities. AMIIF’s Executive Director, Cristobal Thompson, discusses…
Latin America (LatAm) Area Lead for Astellas Sandra Ramirez outlines the Japanese company’s presence in the region, its efforts to partner with local stakeholders to improve patient access, and the…
Mexico’s pharma market, the second largest in Latin America and among the top 15 globally, is set to top USD 13 billion in sales by 2028. Despite the encouraging numbers,…
The director of Mexican pharmaceutical industry association CANIFARMA, Rafael Gual Cosío, speaks out about the current contradictions plaguing Mexico’s pharma sector. Gual Cosío highlights the fact that market growth and…
The latest from Latin American pharma, including Moderna’s push to build a regional presence and partnership network; Pfizer’s health equity challenges in the region; and Brazil’s local manufacturing of AstraZeneca’s…
The latest from Mexican pharma, including government talks with Indian authorities to provide low-cost medicines, a new distribution pilot program led by the military, the authorization of two Lilly monoclonal…
Writing in the November issue of DIA Global Forum, Lawrence Liberti, Mario Alanis, Pravin Chopra, and Silvia Bendiner examine how the COVID-19 pandemic facilitated greater inter-stakeholder collaboration across the healthcare…
During a year where the Mexican economy shrank 8.5 percent, Novartis Mexico experienced a modest one percent growth which Country President Fernando Cruz, qualified as “reasonably good” considering the impacts…
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the country’s vaccination drive, including the upcoming rollout…
While Mexico struggles with its COVID-19 vaccination campaign, residents of the country’s northern states have begun flying to the United States in search of a shot. Fearful of “fake vaccines”…
Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational marijuana. With a population of nearly 130 million people, Mexico would join Canada and…
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s CanSino is filling the gaps left by Western companies, and AMLO’s call for…
See our Cookie Privacy Policy Here
